• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.
    All News #Library

    WINREVAIR Shows Ph2 Proof In PH-HFpEF Patients

    BUSINESSWIRE

    BMS Camzyos Shows Ph3 Efficacy In Adolescent oHCM Trial

    BUSINESSWIRE

    Lilly Taltz, Zepbound Show Strong PsA, Obesity Efficacy

    PR NEWSWIRE

    Repatha Reduces First Major Cardiovascular Event Risk by 31%

    PR NEWSWIRE

    Novartis Data In Nejm: Fabhalta Slows Kidney Decline By 49.3%

    GLOBENEWSWIRE

    Lilly Embraces AI Biotech Insilico Again, Inking $2.75B Collab

    FIERCE BIOTECH

    Centre To Enforce `Essentials` Act For Bulk Drug Price Regulation

    ECONOMICTIMES

    N6 Introduces Icon16 For Autonorm In Lower-Throughput NGS

    PR NEWSWIRE

    Medical AI Wins First-Ever ACC Digital Health Award

    GLOBENEWSWIRE

    Anumana Gets FDA Nod For AI ECG PH Detection Tool

    BUSINESSWIRE

    Nemolizumab Shows Benefit In Pediatric AD At AAD 2026

    BUSINESSWIRE

    Corcept Presents MOMENTUM Trial Data At ACC Session

    BUSINESSWIRE

    Takeda Zasocitinib Shows Durable Skin Clearance In Psoriasis

    BUSINESSWIRE

    Incyte Povorcitinib Shows 54-Week Data In HS At AAD

    BUSINESSWIRE

    Kardigan Tonlamarsen Shows Ph2 Data At ACC.26

    BUSINESSWIRE

    Moonlake Reveals Phase 3 Sonelokimab Trial Results

    GLOBENEWSWIRE

    Sonuszen Formulation Tested For Hearing Support Legitimacy

    GLOBENEWSWIRE

    Vivoryon Updates Glutaminyl Cyclases As Key Targets In DKD

    GLOBENEWSWIRE

    Takeda Clears Path To FDA With Phase 3 Data On $4B Psoriasis Bet

    FIERCE BIOTECH

    Sanofi Shares Phase 3 Amlitelimab Data for AD at AAD Meeting

    PRESS RELEASE

    Protagonist Announces ICOTYDE Phase 3 Data for Severe Psoriasis

    PHARMIWEB

    Rezpegaldesleukin Phase 2B Data Revealed At 2026 AAD Meeting

    PR NEWSWIRE

    NPPA Exempts India`s First Indigenous Antibiotic Nafithromycin

    PHARMABIZ

    Kymera Therapeutics Presents KT-621 Broaden Data at AAD

    GLOBENEWSWIRE

    ICOTYDE Shows 1-Year Efficacy & Safety in Plaque Psoriasis

    PR NEWSWIRE

    New SPRAVATO Data: Robust Effects in Real-World TRD

    GLOBENEWSWIRE

    Alumis` Envudeucitinib Succeeds in Phase 3 Psoriasis Trial

    GLOBENEWSWIRE

    Switch Study Shows Stability With Cobenfy In Patients

    PHARMIWEB

    NEJM Publishes Ph3 VALOR Data For Brepocitinib

    GLOBENEWSWIRE

    Biogen Announces Phase 2 Results for Litifilimab in Lupus in AAD

    GLOBENEWSWIRE

    Steel Power Male Enhancement Evaluation Reveals Full Performance

    GLOBENEWSWIRE

    Arrowhead Pharma Unveils Plozasiran Data On Hypertriglyceridemia

    PHARMIWEB

    Arcutis Presents Phase 2 Data on Infant Atopic Dermatitis at AAD

    GLOBENEWSWIRE

    Alembic Gets USFDA Nod For Paroxetine ER Tablets

    INDPHARMAPOST

    Intensity Therapeutics Reveals 2025 Financial Results

    PR NEWSWIRE

    Regulator Steps Up Oversight Of GLP-1 Drug Distribution Chain

    ECONOMICTIMES

    Rocket Pharma Announces FDA Approval of Kresladi

    PHARMIWEB

    CVC Capital offers $12.6B to buy out Italian pharma Recordati

    FIERCE PHARMA

    Otsuka buys Transcend in $1.2B deal, nabbing MDMA analog

    PR NEWSWIRE

    Novo`s long-acting insulin Awiqli wins FDA nod

    PR NEWSWIRE

    EUROAPI - Availability of 2025 Universal Registration Document

    PRESS RELEASE

    Shreehas Tambe appointed CEO & MD of Biocon, effective April 1

    EXPRESSPHARMA

    Astrazeneca In Vivo Data Shows Potential, Despite Patient Death

    FIERCE BIOTECH

    Adagio Medical Reports Fourth Quarter and Full Year 2025 Results

    BUSINESSWIRE

    Organon VTAMA Shows Ph3 Skin Clearance In AD Patients

    BUSINESSWIRE

    Sensus Files Lawsuit Against SkinCure Oncology

    BUSINESSWIRE

    Ivonescimab Ph3 Data In NSCLC To Be Featured At ELCC 2026

    BUSINESSWIRE

    Lebrikizumab Shows 4-Year Control In Atopic Dermatitis

    BUSINESSWIRE

    Feinstein Predicts Youth Impulsivity From Brain Data

    BUSINESSWIRE

    VIVAZEN Urges Action As US House Reviews 7-OH Act

    BUSINESSWIRE

    LEO Pharma SPEVIGO Shows Long-Term Data In GPP At AAD 2026

    BUSINESSWIRE

    Quanterix Corporation Announces Date of 2026 Annual Meeting

    BUSINESSWIRE

    ZIVO Bioscience Provides Special Letter to Shareholders

    BUSINESSWIRE

    Retractable Technologies Reports Results for 2025

    BUSINESSWIRE

    Enveric Reports Financial Results, Corporate Update

    BUSINESSWIRE

    Lantern Confirms CEO Role, Flags False Third-Party Report

    BUSINESSWIRE

    Zenas BioPharma Prices $300M Conv. Notes, Stock Offering

    GLOBENEWSWIRE

    Werewolf Therapeutics: Q4 & FY 2025 Results, Corporate Updates

    GLOBENEWSWIRE

    Vitti Labs Wins Lawsuit Against FDA On HCT/P Criteria

    PR NEWSWIRE

    Vera Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.